Lonza Walkersville, Inc.

Click Here To EMAIL INQUIRY
Web: http://www.lonza.com/group/en/company/sites/america/lonza_walkersville.html
E-Mail:
Address: 8830 Biggs Ford Rd., Walkersville, Maryland 21793, USA
Phone: +1-(201)-316-9200 | Fax: +1-(301)-845-4024 | Map/Directions >>

Profile: Lonza Walkersville, Inc. is engaged in the production and support of active pharmaceutical ingredients both chemically as well as biotechnologically. We supply products to the pharmaceutical, healthcare and life science industries. We have strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products.

The company was founded in 1984 and is ISO 9001 certified.

FDA Registration Number: 1114298

12 Products/Services (Click for related suppliers)

• B 1-6 Coxsackievirus A 1-24 CF Antisera (FDA Code: GNO / 866.3145)

Coxsackievirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to coxsackievirus in serum. Additionally, some of these reagents consist of coxsackievirus antisera conjugated with a fluorescent dye that are used to identify coxsackievirus from clinical specimens or from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of coxsackievirus infections and provides epidemiological information on diseases caused by these viruses. Coxsackieviruses produce a variety of infections, including common colds, meningitis (inflammation of brain and spinal cord membranes), herpangina (brief fever accompanied by ulcerated lesions of the throat), and myopericarditis (inflammation of heart tissue).

• Balanced Salt Solutions (FDA Code: KIP / 864.2875)

A balanced salt solution or formulation is a defined mixture of salts and glucose in a simple medium. This device is included as a necessary component of most cell culture systems. This media component controls for pH, osmotic pressure, energy source, and inorganic ions.

• Coxsackievirus A 1-24 CF Antigen (FDA Code: GNG / 866.3145)

• Human and Animal Sera (FDA Code: KIS / 864.2800)

Animal and human sera are biological products, obtained from the blood of humans or other animals, that provide the necessary growth-promoting nutrients in a cell culture system.

• Influenza Virus (A, B, C) Antisera (FDA Code: GNW / 866.3330)

Influenza virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to influenza in serum. The identification aids in the diagnosis of influenza (flu) and provides epidemiological information on influenza. Influenza is an acute respiratory tract disease, which is often epidemic.

• Influenza Virus CF Antigen (FDA Code: GNX / 866.3330)

• Mycoplasma Spp Antiserum (FDA Code: GSA / 866.3375)

• Mycoplasma Spp CF Antigen (FDA Code: GSB / 866.3375)

• Neuramininase (FDA Code: IBE / 864.4400)

Enzyme preparations are products that are used in the histopathology laboratory for the following purposes:

• Parainfluenza Virus 1-4 CF Antisera (FDA Code: GQT / 866.3400)

Parainfluenza virus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to parainfluenza virus in serum. The identification aids in the diagnosis of parainfluenza virus infections and provides epidemiological information on diseases caused by these viruses. Parainfluenza viruses cause a variety of respiratory illnesses ranging from the common cold to pneumonia.

• Parainfluenza Virus CF Antigen (FDA Code: GQS / 866.3400)

• Synthetic Cell and Tissue Culture Media and Components (FDA Code: KIT / 864.2220)

Synthetic cell and tissue culture media and components are substances that are composed entirely of defined components (e.g., amino acids, vitamins, inorganic salts) that are essential for the survival and development of cell lines of humans and other animals. This does not include tissue culture media for human ex vivo tissue and cell culture processing applications as described in 876.5885 of this chapter.